Bluejay Diagnostics, Inc. Net Income Loss

Quick Answer

Bluejay Diagnostics, Inc. reported Net Income Loss of -$6.85 million for the year ending 2025.

  • Bluejay Diagnostics, Inc. showed an increase of +11.3% in Net Income Loss from 2024 to 2025.
  • This data is from Bluejay Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Bluejay Diagnostics, Inc.'s Net Income Loss has declined by 491.3%.
  • Historical annual values: Fiscal year 2025: -$6.85 million | Fiscal year 2024: -$7.72 million | Fiscal year 2023: -$9.95 million | Fiscal year 2022: -$9.30 million | Fiscal year 2021: -$3.49 million | Fiscal year 2020: -$1.16 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: